Evaluation of CIN2/3 Lesion Regression in GynTect® DNA Methylation-Marker-Negative Patients in a Longitudinal Study.
Hoyer H, Stolte C, Böhmer G, Hampl M, Hagemann I, Maier E, Denecke A, Hirchenhain C, Patzke J, Jentschke M, Gerick A, Heller T, Hippe J, Wunsch K, Schmitz M, Dürst M.
Hoyer H, et al. Among authors: schmitz m.
Cancers (Basel). 2023 Aug 3;15(15):3951. doi: 10.3390/cancers15153951.
Cancers (Basel). 2023.
PMID: 37568767
Free PMC article.